Matinas biopharma to participate in the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest

Bedminster, n.j., march 22, 2022 (globe newswire) -- matinas biopharma (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology announced today that jerry jabbour, chief executive officer, has been invited to present at the 2022 virtual growth conference, presented by maxim group llc and hosted by m-vest.
MTNB Ratings Summary
MTNB Quant Ranking